|
Volumn 61, Issue 3, 2012, Pages 381-389
|
Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ADULT;
ARTICLE;
BODY MASS;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCIDENCE;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
PREVALENCE;
PROPORTIONAL HAZARDS MODEL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
VIRUS LOAD;
ADULT;
ANTI-HIV AGENTS;
BODY MASS INDEX;
CD4 LYMPHOCYTE COUNT;
FEMALE;
HIV INFECTIONS;
HUMANS;
INCIDENCE;
MALE;
METABOLIC SYNDROME X;
MIDDLE AGED;
PREVALENCE;
PROPORTIONAL HAZARDS MODELS;
RISK FACTORS;
VIRAL LOAD;
MLCS;
MLOWN;
|
EID: 85027917510
PISSN: None
EISSN: 19447884
Source Type: Journal
DOI: 10.1097/qai.0b013e3182690e3c Document Type: Article |
Times cited : (60)
|
References (0)
|